封面
市场调查报告书
商品编码
1306382

製药器械组合药物市场:按产品、用途和最终用户 - 2023-2030 年全球预测

Drug Device Combination Products Market by Product, Application, End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球医药器械组合药物市场预计将以 7.52%的年复合成长率大幅增长,到 2023 年达到 1382.4 亿美元,预计到 2030 年将达到惊人的 2307.1 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球製药器械组合药物市场至关重要。通过检查业务战略和产品满意度的关键指标,我们对供应商进行全面评估,使用户能够根据自己的具体需求做出资讯的决策。这种高级分析将供应商分为四个像限,并取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献,可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解:

1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2. 市场开发:提供有关利润丰厚的新兴市场的详细资讯,并分析其在成熟市场的渗透率。

3. 市场多元化:提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势:全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯:对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题:

1.全球医药器械组合药物市场规模及预测是多少?

2.在预测期内,COVID-19 对全球製药器械组合药物市场的抑制要素和影响有哪些?

3. 在预测期内,全球医药器械组合药物市场需要投资哪些产品/细分市场/应用/领域?

4.你们在全球医药器械组合药物市场的竞争策略是什么?

5.全球製药器械组合药物市场的技术趋势和法律规范是什么?

6.全球医药器械组合药物市场主要供应商的市场份额是多少?

7. 哪些型态和战略倡议被认为适合进入全球药物器械组合药物市场?

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 美国慢性病和癌症的患病率不断上升
      • 患者和医生对微创手术越来越感兴趣
      • 持续剂量特异性治疗的替代方案
    • 抑制因素
      • 产品召回事件增加
    • 机会
      • 製药器械组合药物的研发
      • 製药设备组合药物技术的进步
    • 任务
      • 复杂性和不利的法规批准
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通胀的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户定制

第6章药品器械组合药物市场:副产品

  • 抗菌导管
  • 药物释放型支架
  • 输液泵
  • 吸入器
  • 整形外科组合产品
  • 光动力治疗仪
  • 预充式註射器
  • 经皮吸收贴片
  • 创伤护理产品

第7章药品器械组合药物市场:按用途

  • 抗菌用途
  • 癌症治疗
  • 心血管疾病
  • 糖尿病
  • 呼吸系统的问题

第8章製药器械组合药物市场:按最终用户分类

  • 门诊手术中心
  • 家庭护理设置
  • 医院和诊所

第9章美洲医药器械组合药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太医药器械组合药物市场

  • 澳大利亚
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲医药器械组合药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市场份额分析:主要企业
  • 竞争情景分析:主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可和定价
Product Code: MRR-742BD517D8F6

The Global Drug Device Combination Products Market is forecasted to grow significantly, with a projected USD 138.24 billion in 2023 at a CAGR of 7.52% and expected to reach a staggering USD 230.71 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Device Combination Products Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Device Combination Products Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Photodynamic Therapy Devices, Prefilled Syringes, Transdermal Patches, and Wound Care Products. The Orthopedic Combination Products is projected to witness significant market share during forecast period.

Based on Application, market is studied across Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder, Diabetes, and Respiratory Problem. The Antimicrobial Application is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Ambulatory Surgery Centers, Home Care Settings, and Hospital & Clinic. The Home Care Settings is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Device Combination Products Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Device Combination Products Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Device Combination Products Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Device Combination Products Market?

4. What is the competitive strategic window for opportunities in the Global Drug Device Combination Products Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Device Combination Products Market?

6. What is the market share of the leading vendors in the Global Drug Device Combination Products Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Device Combination Products Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Device Combination Products Market, by Product, 2022 vs 2030
  • 4.3. Drug Device Combination Products Market, by Application, 2022 vs 2030
  • 4.4. Drug Device Combination Products Market, by End-user, 2022 vs 2030
  • 4.5. Drug Device Combination Products Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disease and cancer in the United States
      • 5.1.1.2. The growing patient and physician preference for minimally invasive procedures
      • 5.1.1.3. Consistent-dosing treatment alternatives
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incident of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Research and development in drug device combination products
      • 5.1.3.2. Technological advancement in drug device combination products
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity and unfavorable regulatory approvals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Device Combination Products Market, by Product

  • 6.1. Introduction
  • 6.2. Antimicrobial Catheters
  • 6.3. Drug Eluting Stents
  • 6.4. Infusion Pumps
  • 6.5. Inhalers
  • 6.6. Orthopedic Combination Products
  • 6.7. Photodynamic Therapy Devices
  • 6.8. Prefilled Syringes
  • 6.9. Transdermal Patches
  • 6.10. Wound Care Products

7. Drug Device Combination Products Market, by Application

  • 7.1. Introduction
  • 7.2. Antimicrobial Application
  • 7.3. Cancer Treatment
  • 7.4. Cardiovascular Disorder
  • 7.5. Diabetes
  • 7.6. Respiratory Problem

8. Drug Device Combination Products Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Home Care Settings
  • 8.4. Hospital & Clinic

9. Americas Drug Device Combination Products Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Device Combination Products Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Device Combination Products Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG DEVICE COMBINATION PRODUCTS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DEVICE COMBINATION PRODUCTS MARKET DYNAMICS
  • FIGURE 9. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DRUG DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DRUG DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. DRUG DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 152. DRUG DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 153. DRUG DEVICE COMBINATION PRODUCTS MARKET LICENSE & PRICING